Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
11th July, 2023
A webcast replay will be available approximately 48-hrs after the live webcast.
Johnson & Johnson (NYSE: JNJ) will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin, Company Group Chairman Cardiovascular & Specialty Solutions Group (CSS), Anthony (Tony) Long, VP, Clinical Research, Medical Affairs, Preclinical Research and Jasmina Brooks, President Biosense Webster will represent the Company in a session scheduled at 2:00 pm (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
Medtech Special
- VRAD Co., Ltd. launches two virtual reality-based medical simulators
- Medtronic and Yashoda Group partner up to revolutionise patient care with advanced surgical robotics
- Philips India introduces new Azurion interventional imaging system
- Predictive heart monitoring startup ‘GPx’ secures new investment from NEC X; Joins Elev X! Boost Venture Studio Program
- IIT Ropar designs patented mechanical knee rehab device
- Hospital Sant Pau and Huawei join forces to accelerate digital transformation in healthcare
- Healthium Medtech partners with Healthcare Sector Skill Council (HSSC) to boost skill development in India's healthcare sector
Artificial Intelligence Breakthroughs
- How AI is Propelling Radiology & Medical Imaging Capabilities
- Generative AI: Revolutionizing Diagnostics and Personalized Care
- Indian startup Qure.ai joins hands with Roche to transform healthcare capabilities in APAC
- A10 Networks Launches Integrated AI and Security Solutions to Strengthen Cybersecurity in Healthcare and Beyond
- deepc and AI Centre for Value-Based Healthcare enter a partnership
- GE HealthCare announces AI innovation lab showcasing five new research projects
- Fujita Health University Haneda Clinic to introduce Tumor Portrait test by BostonGene
Robots In Medtech
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
- First-of-its-kind robotic cardiac CoE unveiled in Bengaluru, India
- Medtronic Launches Robotics Experience Studio in Singapore to Advance Training and Innovation in Robotics and AI
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer